Drug
budesonide, glycopyrrolate, and formoterol fumarate
Marketed as BREZTRI.
Generic name
budesonide, glycopyrrolate, and formoterol fumarate
Brand names
BREZTRI
First FDA approval
2020-07-23
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA212122 | BREZTRI | 2020-07-23 | ASTRAZENECA AB |
Manufacturers
ASTRAZENECA AB
Frequently asked questions
When was budesonide, glycopyrrolate, and formoterol fumarate FDA approved?
Earliest FDA approval on record: 2020-07-23.
What brand names are sold as budesonide, glycopyrrolate, and formoterol fumarate?
BREZTRI.
Sources
Appeal a budesonide, glycopyrrolate, and formoterol fumarate denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com